Bone & Joint

Despite normal growth and maturation, young people with type 1 diabetes appear to lag in bone development.

Despite normal growth and maturation, adolescents with type 1 diabetes appear to have reduced bone mass and bone size.

Diabetic women treated with alendronate had increases in bone mineral density of the spine and hip and at all sites. Fosamax, a drug used to increase bone mineral density in older women, works well for women with type 2 diabetes, according to a new report.

Rosiglitazone administration results in significant bone loss.

Fifty years since it was demonstrated that diabetes is associated with loss of bone mass.